HUNTLEY, Ill.--(BUSINESS WIRE)--A preliminary injunction preventing the marketing and sale of Aegis Spine, Inc.’s AccelFix-XT line of expandable medical devices is now in effect. The United States District Court for the Northern District of Illinois issued the injunction after finding that Aegis and its parent company, L&K Biomed Co. Ltd., used Life Spine’s proprietary ProLift expandable cage to develop the AccelFix-XT product line. As the Court explained, Aegis used its access to ProLift as Life Spine’s distributor to “discover the underlying specifications of the ProLift and then shared that information with surgeon consultants and L&K to reverse engineer the ProLift.” Accordingly, the Court found that Life Spine is likely to succeed at trial in proving several of its claims, including breach of contract, breach of fiduciary duty, and misappropriation of trade secrets. The injunction applies to Aegis and all those in active concert or participation with Aegis.
Life Spine’s CEO Michael Butler said of the injunction: “We appreciate the Court’s thorough analysis of the issues and we are gratified that the Court’s order protects the years of hard work spent developing our ProLift series of products.”
About Life Spine
Life Spine is an industry-leading medical device company that specializes in providing innovative, Micro Invasive solutions to address a wide range of spinal pathologies. Life Spine is dedicated to improving the quality of life for patients by increasing procedural efficiency and efficacy through innovative design, uncompromising quality standards, and the most technologically advanced manufacturing platforms. Life Spine is pleased to offer its top-performing ProLift expandable spacer system as part of this mission.
For More Information Contact:
Heather Glaser: hglaser@lifespine.com
